Toroso Investments Boosts MSCI Shares 1

MSCI Inc. provides investment decision support tools, including indices, portfolio risk and performance analytics, and corporate governance products and services. The company operates through four segments, including the Index segment that focuses on developing indexed financial products. MSCI’s latest earnings data showed an EPS of $2.84 for the quarter, higher than analysts’ consensus estimates of $2.71. MSCI also increased its dividend payout from $1.25 to $1.38 per share, with insiders owning 3.02% of the stock. Additionally, the company saw an increase in its stock price, with a market capitalization of $42.95 billion, a PE ratio of 50.10, and a beta of 1.13. With a positive outlook on MSCI’s future, several investment analysts have given the stock a “Moderate Buy” rating, with a consensus target price of $558.10. To stay updated on the latest news and analysts’ ratings for MSCI and related companies, sign up for MarketBeat.com’s FREE daily email newsletter.

MSCI logo

Toroso Investments LLC, a US-based institutional investor, has increased its stake in MSCI Inc. (NYSE:MSCI – Get Rating) by 4.9% in Q3 2022, according to its latest Form 13F filing with the Securities and Exchange Commission. The filing shows that Toroso Investments LLC purchased 100 shares of MSCI, boosting its position in the company. Other institutional investors and hedge funds have also either added or reduced their stakes in the company. BlackRock Inc., for instance, raised its position in MSCI by 2.7% during the same period, now owning 6,732,183 shares of MSCI’s stock worth $2,839,566,000. Bishop Rock Capital L.P. increased its holdings in MSCI by 18,898.0% in Q2 2022, now owning 3,918,722 shares of the technology company’s stock valued at $9,508,000, while State Street Corp increased its holdings in shares of MSCI by 0.8% in Q3 2022, now owning 3,328,864 shares of the technology company’s stock valued at $1,404,082,000.

Several investment banks have issued research reports on MSCI, with Barclays upping its price objective on the company’s shares from $470.00 to $600.00 and giving it an “overweight” rating in a report released on December 2nd, 2022. JPMorgan Chase & Co. also raised its price objective on MSCI from $580.00 to $585.00 and gave it an “overweight” rating in a report released on February 2nd, 2022. Raymond James upped its price target on MSCI from $539.00 to $549.00 and gave it an “outperform” rating, while Oppenheimer raised their price target from $510.00 to $575.00 and gave the stock an “outperform” rating in a research report on February 1st, 2022. According to MarketBeat.com, MSCI has an average rating of “Moderate Buy” and a consensus target price of $558.10.

Despite the varying investment ratings, MSCI has shown strong price performance. Its stock price has risen by over 70% in the past year, and the company has a market capitalization of over $33 billion. Overall, the institutional investors’ recent purchases of MSCI shares, coupled with positive analyst reports and the company’s impressive price performance, make for a bullish outlook on MSCI’s future.

Institutional Ownership by Quarter for MSCI (NYSE:MSCI)

MSCI Inc. (NYSE:MSCI – Get Rating) started trading at $537.09 on Friday, with a fifty-day moving average price of $530.14 and a two-hundred day moving average price of $485.93. The firm has a market capitalization of $42.95 billion, a PE ratio of 50.10, and a beta of 1.13. MSCI’s one year low is $376.41, and its one year high is $572.50.

On January 31st, MSCI posted its quarterly earnings data, revealing an EPS of $2.84 for the quarter, which was higher than analysts’ consensus estimates of $2.71 by $0.13. MSCI’s revenue for the quarter was $576.20 million, compared to analyst estimates of $568.53 million. The company’s revenue was up by 4.8% on a year-over-year basis. During the same quarter last year, the company earned $2.51 EPS, with a net margin of 38.72% and a negative return on equity of 93.24%. As per sell-side analysts, MSCI Inc. is expected to post 12.8 earnings per share for the current fiscal year.

MSCI recently increased its quarterly dividend, which was paid on February 28th to stockholders of record on February 17th. The company’s ex-dividend date was February 16th, and the dividend payout increased from $1.25 to $1.38, representing an annualized dividend of $5.52 and a dividend yield of 1.03%. At present, the company’s dividend payout ratio (DPR) stands at 51.49%.

Insider transactions for MSCI indicate that insider Jennifer H. Mak sold 900 shares of the company’s stock on February 13th, in a transaction valued at $503,901.00. Following the sale, the insider now directly owns 6,843 shares of the company’s stock valued at $3,831,327.27. According to a legal filing with the Securities & Exchange Commission, accessible through this link, insiders own 3.02% of the stock.

In summary, MSCI has been performing well, with a positive EPS that exceeded analysts’ estimates, a rising stock price, and an increased dividend payout. Insider transactions suggest that there is some level of confidence in the company, and overall, there appears to be a bullish outlook on MSCI’s future.

MSCI Inc. offers investment decision support tools, including indices, portfolio risk and performance analytics, and corporate governance products and services. The company operates through four segments: Index, Analytics, ESG and Climate, and All Other-Private Assets. The Index segment focuses on developing indexed financial products. Stay updated on the latest news and analysts’ ratings for MSCI and related companies by signing up for MarketBeat.com’s FREE daily email newsletter.

Don’t miss interesting posts on Famousbio

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Reduce IT Employee Fatigue: Gartner’s Four-Step Plan

Successful organizations must involve top executives, lower organizational layers, IT, and business…

Arrest made in murder of LA Bishop David O’Connell, sources say

Los Angeles police have arrested a person in reference to the homicide…

Actylis: Leading the Chemical Industry

Actylis, a global manufacturer and sourcing expert of critical raw materials and…

Lumen Technologies: Shareholder Class Action

Investors who purchased or acquired common stock of Lumen Technologies may be…